Bladder cancer is a highly prevalent disease and is associated with substantial morbidity, mortality, and cost. However, new advances in treatments and outcomes for bladder cancer have been reported to improve patient quality and quantity of life. This article outlines the recent advances in surgical management of muscle invasive bladder cancer. Bladder cancer (BC) is the ninth most common cancer in India and worldwide.
Although, most of the BCs are superficial, 30% invade past the bladder submucosa/mucosa and are defined as muscle-invasive bladder cancer (MIBC). The muscle invasion is often associated with a high risk of death from distant metastases. Radical cystectomy (RC) has long remained the principal treatment for muscle-invasive bladder cancer (MIBC). Despite radical cystectomy, approximately 50% of patients with MIBC develop metastatic disease within 2 years of diagnosis and…
